mRNAワクチン&mRNA医薬品のグローバル市場展望 2023年-2029年:ワクチン、原薬

◆英語タイトル:mRNA Vaccines and mRNA Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23DC14438)◆商品コード:MMG23DC14438
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年12月
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のmRNAワクチン&mRNA医薬品市場規模と予測を収録しています。・世界のmRNAワクチン&mRNA医薬品市場:売上、2018年-2023年、2024年-2029年
・世界のmRNAワクチン&mRNA医薬品市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のmRNAワクチン&mRNA医薬品市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

mRNAワクチン&mRNA医薬品のグローバル主要企業は、Thermo Fisher、 Merck、 Qiagen N.V.、 CureVac、 In-Cell-Art、 eTheRNA、 Takara Bio Inc.、 Sangamo Therapeutics、 Roche CustomBiotech、 BioNTech、 Tiba Biotechnology、 TriLink Bio Technologies、 Argos Therapeutics、 Moderna Therapeutics、 NEB、 Ethris、 Aldevron、 Promega、 Translate Bioなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、mRNAワクチン&mRNA医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のmRNAワクチン&mRNA医薬品市場:タイプ別、2018年-2023年、2024年-2029年
世界のmRNAワクチン&mRNA医薬品市場:タイプ別市場シェア、2022年
・ワクチン、原薬

世界のmRNAワクチン&mRNA医薬品市場:用途別、2018年-2023年、2024年-2029年
世界のmRNAワクチン&mRNA医薬品市場:用途別市場シェア、2022年
・感染症、癌

世界のmRNAワクチン&mRNA医薬品市場:地域・国別、2018年-2023年、2024年-2029年
世界のmRNAワクチン&mRNA医薬品市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるmRNAワクチン&mRNA医薬品のグローバル売上、2018年-2023年
・主要企業におけるmRNAワクチン&mRNA医薬品のグローバル売上シェア、2022年
・主要企業におけるmRNAワクチン&mRNA医薬品のグローバル販売量、2018年-2023年
・主要企業におけるmRNAワクチン&mRNA医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Thermo Fisher、 Merck、 Qiagen N.V.、 CureVac、 In-Cell-Art、 eTheRNA、 Takara Bio Inc.、 Sangamo Therapeutics、 Roche CustomBiotech、 BioNTech、 Tiba Biotechnology、 TriLink Bio Technologies、 Argos Therapeutics、 Moderna Therapeutics、 NEB、 Ethris、 Aldevron、 Promega、 Translate Bio

*************************************************************

・調査・分析レポートの概要
mRNAワクチン&mRNA医薬品市場の定義
市場セグメント
世界のmRNAワクチン&mRNA医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のmRNAワクチン&mRNA医薬品市場規模
世界のmRNAワクチン&mRNA医薬品市場規模:2022年 VS 2029年
世界のmRNAワクチン&mRNA医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのmRNAワクチン&mRNA医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のmRNAワクチン&mRNA医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:ワクチン、原薬
mRNAワクチン&mRNA医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:感染症、癌
mRNAワクチン&mRNA医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別mRNAワクチン&mRNA医薬品市場規模 2022年と2029年
地域別mRNAワクチン&mRNA医薬品売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Thermo Fisher、 Merck、 Qiagen N.V.、 CureVac、 In-Cell-Art、 eTheRNA、 Takara Bio Inc.、 Sangamo Therapeutics、 Roche CustomBiotech、 BioNTech、 Tiba Biotechnology、 TriLink Bio Technologies、 Argos Therapeutics、 Moderna Therapeutics、 NEB、 Ethris、 Aldevron、 Promega、 Translate Bio
...

This research report provides a comprehensive analysis of the mRNA Vaccines and mRNA Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global mRNA Vaccines and mRNA Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of mRNA Vaccines and mRNA Drugs, challenges faced by the industry, and potential opportunities for market players.
The global mRNA Vaccines and mRNA Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The mRNA Vaccines and mRNA Drugs market presents opportunities for various stakeholders, including Infectious Disease, Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in mRNA Vaccines and mRNA Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global mRNA Vaccines and mRNA Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the mRNA Vaccines and mRNA Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the mRNA Vaccines and mRNA Drugs market.
Market Overview: The report provides a comprehensive overview of the mRNA Vaccines and mRNA Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Vaccine, API), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the mRNA Vaccines and mRNA Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the mRNA Vaccines and mRNA Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the mRNA Vaccines and mRNA Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the mRNA Vaccines and mRNA Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the mRNA Vaccines and mRNA Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the mRNA Vaccines and mRNA Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for mRNA Vaccines and mRNA Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the mRNA Vaccines and mRNA Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
mRNA Vaccines and mRNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Vaccine
API
Market segment by Application
Infectious Disease
Cancer
Global mRNA Vaccines and mRNA Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Thermo Fisher
Merck
Qiagen N.V.
CureVac
In-Cell-Art
eTheRNA
Takara Bio Inc.
Sangamo Therapeutics
Roche CustomBiotech
BioNTech
Tiba Biotechnology
TriLink Bio Technologies
Argos Therapeutics
Moderna Therapeutics
NEB
Ethris
Aldevron
Promega
Translate Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Vaccines and mRNA Drugs, market overview.
Chapter 2: Global mRNA Vaccines and mRNA Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of mRNA Vaccines and mRNA Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Vaccines and mRNA Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global mRNA Vaccines and mRNA Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines and mRNA Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines and mRNA Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines and mRNA Drugs Overall Market Size
2.1 Global mRNA Vaccines and mRNA Drugs Market Size: 2022 VS 2029
2.2 Global mRNA Vaccines and mRNA Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global mRNA Vaccines and mRNA Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top mRNA Vaccines and mRNA Drugs Players in Global Market
3.2 Top Global mRNA Vaccines and mRNA Drugs Companies Ranked by Revenue
3.3 Global mRNA Vaccines and mRNA Drugs Revenue by Companies
3.4 Global mRNA Vaccines and mRNA Drugs Sales by Companies
3.5 Global mRNA Vaccines and mRNA Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 mRNA Vaccines and mRNA Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers mRNA Vaccines and mRNA Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Players in Global Market
3.8.1 List of Global Tier 1 mRNA Vaccines and mRNA Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global mRNA Vaccines and mRNA Drugs Market Size Markets, 2022 & 2029
4.1.2 Vaccine
4.1.3 API
4.2 By Type – Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
4.2.1 By Type – Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
4.2.2 By Type – Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
4.2.3 By Type – Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
4.3.1 By Type – Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
4.3.2 By Type – Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
4.3.3 By Type – Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
4.4 By Type – Global mRNA Vaccines and mRNA Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global mRNA Vaccines and mRNA Drugs Market Size, 2022 & 2029
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application – Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
5.2.1 By Application – Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
5.2.2 By Application – Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
5.2.3 By Application – Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
5.3.1 By Application – Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
5.3.2 By Application – Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
5.3.3 By Application – Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
5.4 By Application – Global mRNA Vaccines and mRNA Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global mRNA Vaccines and mRNA Drugs Market Size, 2022 & 2029
6.2 By Region – Global mRNA Vaccines and mRNA Drugs Revenue & Forecasts
6.2.1 By Region – Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2023
6.2.2 By Region – Global mRNA Vaccines and mRNA Drugs Revenue, 2024-2029
6.2.3 By Region – Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global mRNA Vaccines and mRNA Drugs Sales & Forecasts
6.3.1 By Region – Global mRNA Vaccines and mRNA Drugs Sales, 2018-2023
6.3.2 By Region – Global mRNA Vaccines and mRNA Drugs Sales, 2024-2029
6.3.3 By Region – Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.4.2 By Country – North America mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.4.3 US mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.4.4 Canada mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.4.5 Mexico mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.5.2 By Country – Europe mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.5.3 Germany mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.4 France mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.5 U.K. mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.6 Italy mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.7 Russia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.8 Nordic Countries mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.5.9 Benelux mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.6.2 By Region – Asia mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.6.3 China mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.4 Japan mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.5 South Korea mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.6 Southeast Asia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.6.7 India mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.7.2 By Country – South America mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.7.3 Brazil mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.7.4 Argentina mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa mRNA Vaccines and mRNA Drugs Sales, 2018-2029
6.8.3 Turkey mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.4 Israel mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
6.8.6 UAE mRNA Vaccines and mRNA Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Major Product Offerings
7.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Thermo Fisher Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck mRNA Vaccines and mRNA Drugs Major Product Offerings
7.2.4 Merck mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Company Summary
7.3.2 Qiagen N.V. Business Overview
7.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Major Product Offerings
7.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Qiagen N.V. Key News & Latest Developments
7.4 CureVac
7.4.1 CureVac Company Summary
7.4.2 CureVac Business Overview
7.4.3 CureVac mRNA Vaccines and mRNA Drugs Major Product Offerings
7.4.4 CureVac mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.4.5 CureVac Key News & Latest Developments
7.5 In-Cell-Art
7.5.1 In-Cell-Art Company Summary
7.5.2 In-Cell-Art Business Overview
7.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Major Product Offerings
7.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.5.5 In-Cell-Art Key News & Latest Developments
7.6 eTheRNA
7.6.1 eTheRNA Company Summary
7.6.2 eTheRNA Business Overview
7.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Major Product Offerings
7.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.6.5 eTheRNA Key News & Latest Developments
7.7 Takara Bio Inc.
7.7.1 Takara Bio Inc. Company Summary
7.7.2 Takara Bio Inc. Business Overview
7.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Major Product Offerings
7.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Takara Bio Inc. Key News & Latest Developments
7.8 Sangamo Therapeutics
7.8.1 Sangamo Therapeutics Company Summary
7.8.2 Sangamo Therapeutics Business Overview
7.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sangamo Therapeutics Key News & Latest Developments
7.9 Roche CustomBiotech
7.9.1 Roche CustomBiotech Company Summary
7.9.2 Roche CustomBiotech Business Overview
7.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Major Product Offerings
7.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Roche CustomBiotech Key News & Latest Developments
7.10 BioNTech
7.10.1 BioNTech Company Summary
7.10.2 BioNTech Business Overview
7.10.3 BioNTech mRNA Vaccines and mRNA Drugs Major Product Offerings
7.10.4 BioNTech mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.10.5 BioNTech Key News & Latest Developments
7.11 Tiba Biotechnology
7.11.1 Tiba Biotechnology Company Summary
7.11.2 Tiba Biotechnology Business Overview
7.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Major Product Offerings
7.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Tiba Biotechnology Key News & Latest Developments
7.12 TriLink Bio Technologies
7.12.1 TriLink Bio Technologies Company Summary
7.12.2 TriLink Bio Technologies Business Overview
7.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Major Product Offerings
7.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.12.5 TriLink Bio Technologies Key News & Latest Developments
7.13 Argos Therapeutics
7.13.1 Argos Therapeutics Company Summary
7.13.2 Argos Therapeutics Business Overview
7.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Argos Therapeutics Key News & Latest Developments
7.14 Moderna Therapeutics
7.14.1 Moderna Therapeutics Company Summary
7.14.2 Moderna Therapeutics Business Overview
7.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Major Product Offerings
7.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Moderna Therapeutics Key News & Latest Developments
7.15 NEB
7.15.1 NEB Company Summary
7.15.2 NEB Business Overview
7.15.3 NEB mRNA Vaccines and mRNA Drugs Major Product Offerings
7.15.4 NEB mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.15.5 NEB Key News & Latest Developments
7.16 Ethris
7.16.1 Ethris Company Summary
7.16.2 Ethris Business Overview
7.16.3 Ethris mRNA Vaccines and mRNA Drugs Major Product Offerings
7.16.4 Ethris mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Ethris Key News & Latest Developments
7.17 Aldevron
7.17.1 Aldevron Company Summary
7.17.2 Aldevron Business Overview
7.17.3 Aldevron mRNA Vaccines and mRNA Drugs Major Product Offerings
7.17.4 Aldevron mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Aldevron Key News & Latest Developments
7.18 Promega
7.18.1 Promega Company Summary
7.18.2 Promega Business Overview
7.18.3 Promega mRNA Vaccines and mRNA Drugs Major Product Offerings
7.18.4 Promega mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Promega Key News & Latest Developments
7.19 Translate Bio
7.19.1 Translate Bio Company Summary
7.19.2 Translate Bio Business Overview
7.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Major Product Offerings
7.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Translate Bio Key News & Latest Developments
8 Global mRNA Vaccines and mRNA Drugs Production Capacity, Analysis
8.1 Global mRNA Vaccines and mRNA Drugs Production Capacity, 2018-2029
8.2 mRNA Vaccines and mRNA Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global mRNA Vaccines and mRNA Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 mRNA Vaccines and mRNA Drugs Supply Chain Analysis
10.1 mRNA Vaccines and mRNA Drugs Industry Value Chain
10.2 mRNA Vaccines and mRNA Drugs Upstream Market
10.3 mRNA Vaccines and mRNA Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 mRNA Vaccines and mRNA Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of mRNA Vaccines and mRNA Drugs in Global Market
Table 2. Top mRNA Vaccines and mRNA Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global mRNA Vaccines and mRNA Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global mRNA Vaccines and mRNA Drugs Revenue Share by Companies, 2018-2023
Table 5. Global mRNA Vaccines and mRNA Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global mRNA Vaccines and mRNA Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers mRNA Vaccines and mRNA Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers mRNA Vaccines and mRNA Drugs Product Type
Table 9. List of Global Tier 1 mRNA Vaccines and mRNA Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Vaccines and mRNA Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global mRNA Vaccines and mRNA Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global mRNA Vaccines and mRNA Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Sales, (K Units), 2024-2029
Table 46. Thermo Fisher Company Summary
Table 47. Thermo Fisher mRNA Vaccines and mRNA Drugs Product Offerings
Table 48. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Thermo Fisher Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck mRNA Vaccines and mRNA Drugs Product Offerings
Table 52. Merck mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Qiagen N.V. Company Summary
Table 55. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Offerings
Table 56. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Qiagen N.V. Key News & Latest Developments
Table 58. CureVac Company Summary
Table 59. CureVac mRNA Vaccines and mRNA Drugs Product Offerings
Table 60. CureVac mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. CureVac Key News & Latest Developments
Table 62. In-Cell-Art Company Summary
Table 63. In-Cell-Art mRNA Vaccines and mRNA Drugs Product Offerings
Table 64. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. In-Cell-Art Key News & Latest Developments
Table 66. eTheRNA Company Summary
Table 67. eTheRNA mRNA Vaccines and mRNA Drugs Product Offerings
Table 68. eTheRNA mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. eTheRNA Key News & Latest Developments
Table 70. Takara Bio Inc. Company Summary
Table 71. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Offerings
Table 72. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Takara Bio Inc. Key News & Latest Developments
Table 74. Sangamo Therapeutics Company Summary
Table 75. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Offerings
Table 76. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sangamo Therapeutics Key News & Latest Developments
Table 78. Roche CustomBiotech Company Summary
Table 79. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Offerings
Table 80. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Roche CustomBiotech Key News & Latest Developments
Table 82. BioNTech Company Summary
Table 83. BioNTech mRNA Vaccines and mRNA Drugs Product Offerings
Table 84. BioNTech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. BioNTech Key News & Latest Developments
Table 86. Tiba Biotechnology Company Summary
Table 87. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Offerings
Table 88. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Tiba Biotechnology Key News & Latest Developments
Table 90. TriLink Bio Technologies Company Summary
Table 91. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Offerings
Table 92. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. TriLink Bio Technologies Key News & Latest Developments
Table 94. Argos Therapeutics Company Summary
Table 95. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Offerings
Table 96. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Argos Therapeutics Key News & Latest Developments
Table 98. Moderna Therapeutics Company Summary
Table 99. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Offerings
Table 100. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Moderna Therapeutics Key News & Latest Developments
Table 102. NEB Company Summary
Table 103. NEB mRNA Vaccines and mRNA Drugs Product Offerings
Table 104. NEB mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. NEB Key News & Latest Developments
Table 106. Ethris Company Summary
Table 107. Ethris mRNA Vaccines and mRNA Drugs Product Offerings
Table 108. Ethris mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Ethris Key News & Latest Developments
Table 110. Aldevron Company Summary
Table 111. Aldevron mRNA Vaccines and mRNA Drugs Product Offerings
Table 112. Aldevron mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Aldevron Key News & Latest Developments
Table 114. Promega Company Summary
Table 115. Promega mRNA Vaccines and mRNA Drugs Product Offerings
Table 116. Promega mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Promega Key News & Latest Developments
Table 118. Translate Bio Company Summary
Table 119. Translate Bio mRNA Vaccines and mRNA Drugs Product Offerings
Table 120. Translate Bio mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Translate Bio Key News & Latest Developments
Table 122. mRNA Vaccines and mRNA Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global mRNA Vaccines and mRNA Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global mRNA Vaccines and mRNA Drugs Production by Region, 2018-2023 (K Units)
Table 125. Global mRNA Vaccines and mRNA Drugs Production by Region, 2024-2029 (K Units)
Table 126. mRNA Vaccines and mRNA Drugs Market Opportunities & Trends in Global Market
Table 127. mRNA Vaccines and mRNA Drugs Market Drivers in Global Market
Table 128. mRNA Vaccines and mRNA Drugs Market Restraints in Global Market
Table 129. mRNA Vaccines and mRNA Drugs Raw Materials
Table 130. mRNA Vaccines and mRNA Drugs Raw Materials Suppliers in Global Market
Table 131. Typical mRNA Vaccines and mRNA Drugs Downstream
Table 132. mRNA Vaccines and mRNA Drugs Downstream Clients in Global Market
Table 133. mRNA Vaccines and mRNA Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. mRNA Vaccines and mRNA Drugs Segment by Type in 2022
Figure 2. mRNA Vaccines and mRNA Drugs Segment by Application in 2022
Figure 3. Global mRNA Vaccines and mRNA Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Vaccines and mRNA Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global mRNA Vaccines and mRNA Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. mRNA Vaccines and mRNA Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by mRNA Vaccines and mRNA Drugs Revenue in 2022
Figure 9. By Type - Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global mRNA Vaccines and mRNA Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global mRNA Vaccines and mRNA Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 23. US mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 28. Germany mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 37. China mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 44. Brazil mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share, 2018-2029
Figure 48. Turkey mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE mRNA Vaccines and mRNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global mRNA Vaccines and mRNA Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production mRNA Vaccines and mRNA Drugs by Region, 2022 VS 2029
Figure 54. mRNA Vaccines and mRNA Drugs Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ mRNAワクチン&mRNA医薬品のグローバル市場展望 2023年-2029年:ワクチン、原薬(mRNA Vaccines and mRNA Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。